caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1194249565

Mohammed JaloudiMD

Hematology-OncologyProvidence, RII
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
FACILITY AFFILIATIONS

Hospital & Facility Affiliations (5)

CCN 050077
Hospital
CCN 050424
Hospital
CCN 050503
Hospital
CCN 410009
Hospital
CCN 410010
Hospital
QUALITY · MIPS · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
845
Beneficiaries
—
Total drug cost
$552K
Distinct drugs
15
Brand share
4.7%
Top prescribed drugs
Anastrozole414 claims
Letrozole66 claims
Tamoxifen Citrate57 claims
Abiraterone Acetate53 claims
Exemestane48 claims
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
1,608
Unique beneficiaries
—
Total services
30,389
Distinct HCPCS
41
Medicare payment
$504K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 46 Hematology-Oncology providers in RI — top quintile (cohort median 408).
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$29K
Payment records
97
By payment type
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$23K
Consulting Fee$3K
Food and Beverage$3K
Travel and Lodging$1K
Long term medical supply or device loan$333